Singclean Creatine Kinase Isoenzyme MB (CK-MB) Rapid Test Kit (Fluorescence Immunochromatography)

Name: Singclean Creatine Kinase Isoenzyme MB (CK-MB) Rapid Test Kit (Fluorescence Immunochromatography)
Brand: Hangzhou Singclean Medical Products Co., Ltd.
SKU: 2095208375

Zhejiang, ChinaHangzhou Singclean Medical Products Co., Ltd.

US$0.05-2.00

1,000 Pieces

Sample price:US$5.00/piece.Request sample

Product profile

Customization

Available

Type

IVD Reagent

Material

Plastic

Model NO.

POCT

Quality Guarante

2 Years

Sensitivity

92.15%-99.05%

Specificity

97.47%-99.61%

Accuracy

97.19%-99.33%

Lead Time

3-8 Days After Payment

Certification

CE, Doc, ISO, Who(in Application)

When to Test

Early Stage of Infection

Symptoms

Fever, Cough, Fatigue, Shortness of Breath

Test Time

10-15 Minutes

Sample

Nasal Swab

Storage

4-30 Degree

Main Market

Europe

Transport Package

Carton or Customized Package

Specification

20 tests/box, 1 test/box

Trademark

Singclean or Customized brand

Origin

China

HS Code

3002150050

Production Capacity

1 Million PCS/Week

Company profile

Hangzhou Singclean Medical Products Co., Ltd.

Zhejiang, China

CertifiedBusiness Type: Manufacturer/Factory & Trading Company CertifiedR&D Capacity: ODM Service AvailableExport Year: 2022-12-20 CertifiedNearest Port: Ningbo Port, Shanghai PortAverage Response Time: ≤3.18h CertifiedTerms of Payment: LC, T/T, D/P, etc.

AI-Powered supplier vetting

SummaryThe supplier is a China-based medical-products factory headquartered in Hangzhou, Zhejiang, with 420 employees and operations established in the early 2000s. It reports seven production lines, a 17,000 m² manufacturing plant, ISO 9001:2015 and ISO 14001:2015 certification, OEM/ODM services, and stated antigen rapid test-kit capacity of 10 million pieces annually. Its products and services cover in-vitro diagnostics, absorbable hemostatic products, hyaluronic-acid-related medical products, and other medical devices. The supplier reports export coverage across multiple global regions, more than 120 export destinations in a company description, and delivery within 15 working days off-peak or one month during peak periods. Evidence supports strengths in factory operations, quality systems, production scale, customization, and R&D. After-sales capability, financial credibility, and specific customer cases are not sufficiently documented in the provided slices.

Supplier typeThe supplier is identified as a manufacturing factory in Hangzhou, China, with a limited-company structure and medical-device products as its main offering. This supports classification as a direct medical-products manufacturer rather than only a trading intermediary.

CertificationsThe supplier reports ISO 9001:2015 and ISO 14001:2015 certifications, along with other unspecified certifications. These explicitly indicate documented quality-management and environmental-management systems, although the unspecified certifications cannot be assessed further.

R&D capabilityThe supplier reports dedicated R&D engineers, more than 20 years of absorbable-biomaterials expertise, a strong R&D team, and ongoing development of medical and tissue-engineering products. The slices explicitly support substantial innovation activity and industry experience.

Production capacityThe supplier reports a 17,000 m² plant, seven production lines, daily capacity of 500,000 pieces in a company description, annual antigen rapid test-kit output of 10 million pieces, and stated delivery times of within 15 working days off-peak and one month during peak season. These figures provide explicit evidence of meaningful production scale and fulfillment capability.

Customization capabilityThe supplier explicitly offers OEM and ODM services according to client needs. This is direct evidence that it can support customized product development or manufacturing arrangements.